U.S. Biotech Stock News

In recent days, Sunoco LP has drawn attention ahead of its past earnings release, as analysts projected year-over-year improvements in earnings per share and revenue while estimate revisions signaled shifting expectations. At the same time, research firms have offered mixed signals, with an 'Overweight' rating from Wells Fargo contrasting with a Zacks Rank of #4 (Sell), highlighting differing views on Sunoco’s near-term prospects. We’ll now examine how this mix of upbeat earnings...

If you are trying to figure out whether Medpace Holdings at around US$450 per share is still good value, you are not alone. This article is written with that question front and center. The stock has had a mixed run recently, with a 4.3% decline over the last 7 days, a 5.2% gain over 30 days, a 21.1% decline year to date, yet a 38.6% return over 1 year and a 156.4% return over 3 years. These moves have kept Medpace on many investors' watchlists, with attention on how its contract research...

In early March 2026, Prudential Financial’s board made Chief Executive Officer Andrew Sullivan chairman as well, following Charles Lowrey’s resignation and transition to a senior advisory role ahead of his retirement. At the same time, Prudential paused new sales in its Japan business to address misconduct and expects this to significantly affect 2026 earnings, underscoring how leadership and operational changes are intersecting at a critical moment for the company. We’ll now explore how...

Why Donaldson Company is on investors’ radar today Donaldson Company (DCI) has drawn fresh attention after recent trading left the shares with a one-month return of a 21.6% decline and a past three-month return of a 7.3% decline, prompting closer review of its fundamentals. See our latest analysis for Donaldson Company. Zooming out, the recent 21.6% one month share price decline and softer 7.3% three month share price return sit against a much stronger 27.2% one year total shareholder return...

In early March 2026, Broadridge Financial Solutions announced several moves, including integrating Crypto.com into its global NYFIX order-routing network, enhancing ProxyVote with pass-through voting for Vanguard investors, appointing a new Chief Growth and Strategy Officer, and affirming a quarterly dividend of US$0.975 per share payable on April 8, 2026. Together, these steps highlight how Broadridge is linking traditional market plumbing with digital assets, expanding shareholder voting...

Earlier this week, Kyivstar Group Ltd. reported its full-year 2025 results, with sales rising to US$1,157 million from US$919 million, even as net income fell to US$124 million from US$283 million and basic EPS from continuing operations declined to US$0.57 from US$1.37. The company also issued 2026 guidance calling for USD revenue growth of 8%–11%, underlining management’s confidence in further expanding its fast-growing digital and connectivity ecosystem despite a volatile operating...

Recently, JPMorgan Chase moved to restrict lending to private credit providers after marking down several loans, prompting firms like Carlyle Group to curb redemptions in key funds amid rising concern about stresses in the private credit market. This tension is surfacing just as Carlyle is pushing ahead with initiatives like its large “Project Potomac” collateralized fund obligation and portfolio streamlining, highlighting how financing conditions can influence alternative asset managers’...

In March 2026, Texas Capital Bancshares announced it will redeem all US$375,000,000 of its 4.000% fixed-to-fixed rate subordinated notes due 2031 on May 6, 2026, at par plus accrued and unpaid interest, under its existing indenture with U.S. Bank Trust Company as trustee. This move, alongside recent insider share purchases and a rebound in quarterly profitability, points to management confidence in the bank’s balance sheet and earnings profile. We’ll now examine how the planned subordinated...

In recent days, Intuitive Surgical reported that a targeted phishing-related cybersecurity incident allowed an unauthorized third party to access certain internal IT business applications containing limited customer and employee data, while confirming that its da Vinci and Ion surgical platforms remained secure and fully operational. The incident highlights how cybersecurity and data governance have become material operational considerations even for MedTech companies whose core value...

Why Sunstone Hotel Investors Is Back on Investors’ Radar Sunstone Hotel Investors (SHO) is drawing fresh attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year, and 5 years. At the same time, the lodging focused real estate investment trust reports annual revenue of US$960.1 million and net income of US$8.2 million. These figures give investors a starting point for assessing how the current share price...

Akso Health Group recently reported revenue growth of 75.6%, coinciding with its shares reaching a fresh 52-week high in past trading. This combination of rapid top-line expansion and a record-year price level highlights how operational momentum can reshape perceptions of the company’s prospects. Next, we will examine how this rapid revenue growth influences Akso Health Group’s investment narrative in light of its recent share price gains. We've uncovered the 14 dividend fortresses yielding...

Recent moves by large institutional investors to lift their positions in DTE Energy (DTE), along with multi billion dollar capital spending on infrastructure and cleaner power, have put the Michigan utility back in focus for many shareholders. See our latest analysis for DTE Energy. That renewed institutional interest is coming alongside a clear pickup in momentum, with DTE Energy’s 90 day share price return of 16.12% and year to date share price return of 14.74% sitting alongside a 5 year...

Burlington Stores reported past fourth-quarter 2026 results with sales of US$3,642.50 million and net income of US$310.39 million, alongside higher earnings per share and a small increase in impairment charges, while completing a share repurchase of 223,863 shares for US$59.00 million. Management attributed this performance to its elevation focus on higher-quality branded apparel, footwear, and beauty, and issued guidance calling for further total sales growth underpinned by modest...

In past days, OGE Energy Corp reported Q4 2025 results with earnings per share of $0.34 on US$725.80 million in revenue, exceeding analyst expectations on both metrics. This earnings and revenue surprise, supported by generally positive analyst commentary and fresh coverage, highlights investor interest in OGE’s regulated utility model and customer base in Oklahoma and western Arkansas. Building on this earnings beat, we’ll now examine how the stronger-than-expected results could influence...

In the past week, Yum! Brands reported strong Q4 2025 results, with revenue and same-store sales beating expectations, operating profit up 12%, and more than 4,500 new KFC, Taco Bell and Pizza Hut restaurants opened worldwide in 2025. This performance underlines how Yum!’s franchise-led, asset-light model is scaling globally, with Taco Bell’s 7% same-store sales growth and rapid expansion emerging as a key earnings pillar. We’ll now examine how this better-than-expected Q4 performance and...

Capricor Therapeutics (CAPR) is back in focus after the FDA resumed review of its Biologics License Application for Deramiocel, supported by new HOPE-3 Phase 3 data in Duchenne muscular dystrophy cardiomyopathy. See our latest analysis for Capricor Therapeutics. The FDA decision and fresh HOPE-3 data arrived after a strong run, with a 30 day share price return of 35.86% and a one year total shareholder return of 130.54%. This comes even though the stock has pulled back 8.74% on the day to...

Why Pool stock is drawing attention now Pool (POOL) has been catching investor interest after a stretch of weak share performance, including negative returns over the past month and past 3 months, set against a backdrop of ongoing revenue and net income growth. See our latest analysis for Pool. Pool’s recent 1 day share price return of 1.23% follows a 30 day share price decline of 22.27% and a 1 year total shareholder return decline of 35.66%, which suggests that momentum may still be...

Estée Lauder Companies (EL) has moved into the spotlight after launching legal action against perfumer Jo Malone, her current brand Jo Loves, and Zara over alleged breaches involving the Jo Malone name. See our latest analysis for Estée Lauder Companies. The legal dispute comes after a tough stretch for Estée Lauder’s share price, with a 30 day share price return showing an 18.81% decline and a year to date share price return showing a 17.68% decline. Over a 1 year period, the total...

Constellium SE has authorized a new share repurchase program of up to US$300 million running through December 31, 2028, replacing its prior buyback plan and using some repurchased shares to meet employee equity obligations and limit dilution. This move highlights how Constellium is pairing capital returns with tighter share count management as its main business segments show improving momentum. Now we’ll examine how this sizable repurchase authorization, aimed at curbing future dilution,...

Why the new asset backed notes matter for Avis Budget Group (CAR) Avis Budget Group (CAR) has issued Series 2026-1 asset backed notes secured by its U.S. vehicle fleet and related receivables, a financing move that reshapes its liquidity profile and capital structure. See our latest analysis for Avis Budget Group. At a share price of $100.71, Avis Budget Group has a 1-day share price return of 1.16% and a 7-day share price return of 3.28%. The 30-day and year to date share price returns of...

If you are wondering whether Aurora Innovation's current share price reflects its true potential, this article walks through what the numbers actually say about value. The stock closed at US$4.08 recently, with a 7 day return of a 9.1% decline, a 30 day return of an 8.9% decline, a 5.4% gain year to date, and a 41.5% decline over the past year, while the 3 year return is very large. Recent market attention has focused on Aurora Innovation's role in autonomous driving technology and...

TSS (TSSI) drew fresh attention after reporting fourth quarter 2025 results, with revenue of US$60.91 million and net income of US$12.16 million, alongside an amended AI rack integration agreement. See our latest analysis for TSS. The latest earnings beat and AI rack integration update come after a sharp run in the shares, with a 31.90% 7 day and 46.81% 30 day share price return. The 1 year total shareholder return of 23.83% and very large 3 year total shareholder return suggest momentum has...

In the past week, US Foods Holding reported Q4 2025 results with adjusted earnings per share exceeding estimates on the back of tighter cost controls and improved operational efficiency, while simultaneously setting ambitious fiscal 2026 targets for adjusted EPS and EBITDA growth despite a revenue shortfall and weaker gross profit margin. An interesting angle for investors is that, even as revenue quality and margin pressures draw scrutiny, analysts have been revising earnings forecasts...

If you are wondering whether Bath & Body Works is attractively priced after its recent share performance, this article walks through what the current stock price might be implying about the business. The share price last closed at US$19.50, with returns of 6.2% decline over 7 days, 19.0% decline over 30 days, 6.0% decline year to date and 31.5% decline over 1 year, while the 3 year and 5 year returns are 38.7% decline and 55.5% decline respectively. Recent coverage around Bath & Body Works...